Written by: LaurieAnn Scher, MS, RD, CDCES, FADCES
Updated: May 28, 2025
For individuals with diabetes, particularly those requiring intensive insulin therapy, the right insulin pump can mean the difference between daily frustration and meaningful control. And for healthcare professionals, helping a patient navigate this increasingly complex decision is a task that goes far beyond comparing gadgets. With the rapid evolution of automated insulin delivery (AID) systems, sensor integration, and user interfaces, today’s pump landscape demands a nuanced approach rooted in both clinical insight and patient-centered care.
At danatech, we believe choosing a pump isn’t just about what’s available, it’s about what fits. Here's what HCPs should consider when guiding patients through this essential decision.
Conventional wisdom has long held that insulin pump therapy requires a high level of engagement, math skills, and technological comfort. But as pumps and particularly automated insulin delivery (AID) systems have grown more intuitive and less burdensome to operate, it’s time to revisit what “readiness” truly means.
While foundational skills like understanding hypoglycemia, meal timing, and insulin action remain essential, the threshold for successful pump use has lowered for many patients, especially those transitioning from MDI to AID with strong support.
Instead of framing readiness as a gatekeeping checklist, consider a more inclusive question: What kind of support and training would this patient need to succeed with a pump? For some, that means structured pump start programs or additional digital literacy coaching. For others, the design of the pump itself—such as app-based control, simplified meal announcements, or built-in dosing automation—may remove traditional barriers.
This shift is especially important for reaching underserved populations, including older adults, people with lower health literacy, or those historically excluded from technology due to perceived “non-readiness.”
What to look for instead:
Rather than saying no outright, HCPs should ask, What would it take to make this a yes?
Cost remains a primary deciding factor for many patients. Insulin pumps can be obtained through either the pharmacy benefit or durable medical equipment (DME), depending on the system. For instance, tubeless systems like Omnipod are typically covered under pharmacy benefits, which may offer greater affordability or different restrictions compared to DME-channel pumps.
As coverage policies vary by plan and region—and often change without much notice—it’s essential to check each patient’s benefit structure carefully. Coverage doesn’t just affect the pump itself, but also the supplies, training, and support services critical to long-term success.
Consider:
DME vs. pharmacy benefit (e.g., Omnipod vs. tubed pumps)
Out-of-pocket costs, co-pays, and deductibles
Medicare/Medicaid nuances
The age-old question—tubed or tubeless—isn’t one-size-fits-all. Tubeless systems offer a discreet, body-worn experience and are sometimes preferred by younger users, athletes, or individuals who find tubing cumbersome. But some patients appreciate the flexibility of being able to disconnect a tubed pump during showers, intimacy, or contact sports.
It’s also worth noting that infusion set options are generally more diverse with traditional tubed pumps, which may better serve patients with skin sensitivities or high basal needs.
Ultimately, comfort, aesthetics, and routine should all factor into this deeply personal choice.
Modern pumps do more than deliver insulin—they think, alert, adapt, and even automate insulin delivery in response to CGM data.
Today’s devices may include:
For clinicians, these features aren’t fluff—they’re critical to aligning pump functionality with patient behavior. For example, a shift worker may need flexible basal adjustments, while a tech-savvy teen may engage more fully with a smartphone-controlled device.
👉 Use the automated insulin pump comparison tool to explore features side-by-side.
Perhaps the most transformative change in pump therapy is the widespread adoption of Automated Insulin Delivery (AID) systems, which integrate with continuous glucose monitors (CGMs) to adjust basal insulin based on real-time glucose data.
Some pumps are simply CGM-compatible, offering display-only integration. Others operate full AID loops, using algorithms to predict and respond to glycemic excursions automatically. Notable examples include:
These systems offer compelling improvements in Time-in-Range and glycemic variability but come with trade-offs, such as data-sharing requirements, calibration needs, or locked hardware ecosystems.
Many manufacturers now offer app-based simulators or even non-functioning device kits that allow patients to try pumps at home before committing. These tools let users simulate bolus delivery, explore menus, and even wear sample devices during daily routines.
For example, Insulet offers a 30-day trial of Omnipod 5, along with an Experience Kit containing a demo Pod. These “try before you buy” tools are invaluable for setting expectations and reducing dropout rates.
👉 Visit our Apps & Platforms section to explore simulator apps by brand.
Don’t overlook the logistics. Prescribing a pump often involves:
Whether you're handling pump starts in-house or referring out, it's vital to ensure your patient has access to a comprehensive onboarding program. This may include both in-person training and app-based video modules.
Perhaps most importantly: pump selection isn’t a single decision, it's continuous conversation. Patients’ lives change. Their tech needs evolve. And just as importantly, technology itself progresses rapidly.
Encourage patients to voice frustrations or questions early and provide space for re-evaluation. What fits today may not tomorrow. That’s okay. The best pump is one that serves the patient’s needs and not the other way around.
In the ever-expanding universe of diabetes technology, insulin pumps and AIDs remain central to modern care. But with choice comes complexity. Your role as a healthcare professional is not simply to prescribe, but to personalize.
By considering coverage, features, integration, and patient lifestyle, you can guide your patients toward a pump that truly fits—not just physically, but holistically.
Explore Further
References:
Pettus J, Price DA, Edelman SV. Artificial Pancreas: Current Status and Future Prospects in the Management of Diabetes. Clin Pharmacol Ther. 2020;107(1):50–58.
Grunberger G, Sherr J, Allende M, et al. AACE Consensus Statement: Automated Insulin Delivery. Endocr Pract. 2022;28(8):780–800.
Gonder-Frederick L, Shepard JA, Grabman JH, et al. Assessing Readiness for Insulin Pump Therapy: Ethical and Practical Considerations. Diabetes Technol Ther. 2017;19(1):1–4.
Fleming GA, Petrie JR, Bergenstal RM, et al. Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. Diabetes Technol Ther. 2020;22(1):1–17.
Powers MA, Bardsley J, Cypress M, et al. Diabetes Self-management Education and Support in Adults with Type 2 Diabetes: A Consensus Report. Diabetes Educ. 2020;46(4):350–369.
Zhou W, Christian J, Tseng E, et al. Health Disparities and the Digital Divide: A Call for Inclusive Innovation in Diabetes Technology. J Diabetes Sci Technol. 2021;15(4):789–793.
American Diabetes Association. Standards of Care in Diabetes—2024. Diabetes Care. 2024;47(Suppl 1):S1–S350
ADCES. Tech Check: Assessing and Advancing Readiness for Diabetes Device Use. ADCES Practice Tools.
DISCLAIMERS: 
This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit the ADCES finder tool.
ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.